Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Studying Behavior of Acanthamoeba to Develop Targeted Strategies for Preventing Acanthamoeba Keratitis
Published on: September 20, 2024
(‒)-Epicatechin enhances the anti-Acanthamoeba activity of chlorhexidine through synergistic action
Hương Giang Lê1, Tuấn Cường Võ1, Thu Hằng Nguyễn1
1Department of Parasitology and Tropical Medicine, and Institute of Health Science, Gyeongsang National University College of Medicine, Jinju 52727, South Korea; Department of Convergence Medical Science, Gyeongsang National University, Jinju 52727, South Korea.
Abstract:
Acanthamoeba species are causative agents of the sight-threatening ocular disease, Acanthamoeba keratitis (AK). (‒)-Epicatechin (EC) has been reported to exhibit anti-amoebic activity against laboratory strains of A. castellanii and A. polyphaga, suggesting its potential as an AK drug alternative. However, its efficacy against clinical isolates of Acanthamoeba species and its feasibility as a treatment for AK have not yet been investigated. In this study, we analyzed the anti-amoebic activity of EC against Acanthamoeba clinical isolates and its synergistic effect with chlorhexidine (CHX) to validate its potential in developing or optimizing AK treatment regimes. The anti-amoebic activity of EC against trophozoites and cysts of 10 clinical isolates of Acanthamoeba species was analyzed. The synergistic anti-amoebic effect of EC and CHX was also investigated. EC exhibited anti-amoebic activity against clinical isolates of Acanthamoeba, but showed varying efficacy, with IC50 values ranging from 43.24 to 271.30 µM against trophozoites. EC induced apoptosis-like programmed cell death in the trophozoites of these clinical isolates, and also had partial cysticidal activity. Co-treatment with EC and CHX exhibited prominent in vitro synergistic anti-amoebic activity against Acanthamoeba trophozoites and cysts, and co-treatment with EC and a subclinical dose of CHX (0.001 and 0.002%) revealed a dose-dependent anti-amoebic effect on both trophozoites and cysts equivalent to or greater than a clinical dose of CHX (0.02%). The promising anti-amoebic activity of EC against Acanthamoeba clinical isolates, along with the observed synergistic effect with CHX, highlights its potential as a drug candidate or an adjunctive treatment for AK.
Related Concept Videos
Fixed Action Patterns
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Action Potentials
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

